PRODUCT QUALITY ISSUE

This adverse event was reported 135959 times

These drugs are most commonly taken by patients reporting PRODUCT QUALITY ISSUE:

# Drug Count
0 ETONOGESTREL 6915
1 TIOTROPIUM BROMIDE 5982
2 ALBUTEROL SULFATE 5778
3 METHYLPHENIDATE 5249
4 MOMETASONE FUROATE 4526
5 MOMETASONE FUROATE AND FORMOTEROL FUMARATE DIHYDRATE 3321
6 LIDOCAINE 3211
7 LIDOCAINE 4% 3191
8 LEVOTHYROXINE SODIUM 2807
9 LISINOPRIL 2754
See all common drugs associated with PRODUCT QUALITY ISSUE

PRODUCT QUALITY ISSUE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 MOMETASONE FUROATE AND FORMOTEROL FUMARATE DIHYDRATE 3321 0.2047
1 NICOTINE TRANSDERMAL SYSTEM PATCH 944 0.2021
2 ETONOGESTREL 6915 0.1201
3 MOMETASONE FUROATE 4526 0.1059
4 ACLIDINIUM BROMIDE 592 0.0926
5 ERGOCALCIFEROL 2602 0.0875
6 GOLIMUMAB 883 0.0701
7 PSEUDOEPHEDRINE HCL 656 0.0599
8 LIDOCAINE 4% 3191 0.0578
9 BOTULINUM TOXIN TYPE A 670 0.0524
See all drugs enriched for association with PRODUCT QUALITY ISSUE

PRODUCT QUALITY ISSUE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 726 1.0552
1 Guanylate Cyclase-C Agonist [EPC] 188 0.0906
2 Provitamin D2 Compound [EPC] 2603 0.0875
3 Cholecystokinin Analog [EPC] 11 0.0719
4 Central Nervous System Stimulant [EPC] 5935 0.0679
5 Sucrose-specific Enzyme [EPC] 12 0.0663
6 Cholinergic Nicotinic Agonist [EPC] 2503 0.0409
7 Amide Local Anesthetic [EPC] 3403 0.0390
8 Antiarrhythmic [EPC] 3462 0.0348
9 Gonadotropin [EPC] 71 0.0324
See all drug classes enriched for association with PRODUCT QUALITY ISSUE